Nathan Wan

Title: Innovator Spotlight: Nathan Wan

Introduction

Nathan Wan, an accomplished inventor based in South San Francisco, CA, has significantly contributed to the field of diagnostic technologies. With a total of two patents to his name, Wan is actively revolutionizing how cancer diagnostics are approached through innovative applications of machine learning.

Latest Patents

Wan's recent patent focuses on a cutting-edge machine learning implementation for multi-analyte assay development and testing. This invention details systems and methods designed to analyze blood-based cancer diagnostic tests using various classes of molecules. The system utilizes machine learning (ML) to examine multiple analytes, such as cell-free DNA, cell-free microRNA, and circulating proteins derived from biological samples. The approach encompasses multiple assays, including whole-genome sequencing, whole-genome bisulfite sequencing, small-RNA sequencing, and quantitative immunoassays. By leveraging independent information between signals, this innovative system enhances the sensitivity and specificity of diagnostics, providing a more thorough analysis for detecting cancerous properties in samples.

Career Highlights

Nathan Wan is currently associated with Freenome Holdings, Inc., a forward-thinking company focused on integrating technology and biology for improved healthcare solutions. His work and innovations are poised to make a significant impact on early cancer detection methods, demonstrating a deep commitment to advancing medical science through technology.

Collaborations

Throughout his career, Wan has collaborated with notable colleagues such as Adam Drake and Daniel Delubac, working alongside them at Freenome Holdings, Inc. This environment of collaboration fosters innovation and supports the development of groundbreaking technologies in the field of diagnostics.

Conclusion

Nathan Wan's contributions to the field of cancer diagnostics through innovative applications of machine learning emphasize the importance of technological advancements in healthcare. As an inventor at Freenome Holdings, Inc., his pioneering work continues to push the boundaries of what is possible in medical diagnostics, ultimately improving patient outcomes and advancing research in the field.